Page last updated: 2024-11-02

phenobarbital and Cardiac Septal Defect

phenobarbital has been researched along with Cardiac Septal Defect in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuoka, R1
Gilbert, EF1
Bruyere, HJ1
Fang, TT1
Nishikawa, T1
Opitz, JM1

Other Studies

1 other study available for phenobarbital and Cardiac Septal Defect

ArticleYear
Experimentally induced cardiovascular malformations in the chick embryo. Part II. Teratogenic effect of Tedral (theophylline, ephedrine, and phenobarbital) on cardiac development in chick embryos.
    Birth defects original article series, 1987, Volume: 23, Issue:1

    Topics: Animals; Cardiovascular System; Chick Embryo; Dose-Response Relationship, Drug; Drug Combinations; D

1987